Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

Parthika Patel12 Oct 2025 10:30 AM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked Enzene Biosciences Ltd to revise...

Murder of Amravati Chemist a 'Terror Act', Rules NIA Court, Denies Bail to Accused

Parthika Patel12 Oct 2025 10:00 AM IST

Mumbai: Describing the murder of Amravati chemist Umesh Kolhe as a meticulously planned "act of terror" meant to instill fear and hatred, a special...

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC

CDSCO Panel Seeks More Safety Data from Raptim Research on Lenalidomide Patch

Parthika Patel11 Oct 2025 1:41 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked Raptim Research Pvt Ltd to...

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps

AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors

Parthika Patel10 Oct 2025 8:09 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval for an additional...

Lupin unveils authorized generic version of Ravicti in US

Lupin Launches Strategic Partnership to Expand PrecisionSphere Long-Acting Injectable Platform

Parthika Patel10 Oct 2025 4:29 PM IST

New Delhi: Global pharma major Lupin Limited (Lupin) today announced the launch of a strategic partnership program aimed at expanding the reach of...

Chemist Loses Rs 1.01 Crore in Social Media Investment Scam

Parthika Patel10 Oct 2025 4:08 PM IST

Rajkot: A chemist in Gondal district fell prey to a high-stakes cyber fraud, losing Rs 1.01 crore after being lured by a fraudulent investment scheme...

Dispensing Without Pharmacist to Invite Jail Term, Warns Gwalior CMHO

Bhopal Pharmacy Owner Gets 3-Year Jail Sentence for Running Store Without Pharmacist

Parthika Patel10 Oct 2025 4:03 PM IST

Bhopal: In a strict enforcement of pharmaceutical regulations, a Bhopal court has sentenced the owner of a medical store to three years' imprisonment...

Chemists Launch Indefinite Strike Over Coldrif Tragedy, Demand Action Against Manufacturers Not Sellers

Parthika Patel9 Oct 2025 10:54 PM IST

Bhopal: The Chhindwara Chemist Association has launched an indefinite strike starting midnight to protest the sealing of five chemist shops linked to...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Parthika Patel9 Oct 2025 8:58 PM IST

Chennai: Officials from the Tamil Nadu Drugs Control Department uncovered horrific conditions at the Sresan Pharmaceuticals unit in Kancheepuram,...

Drugs Control Officials Caught Taking Rs 20,000 Bribe in Telangana

Parthika Patel8 Oct 2025 7:34 PM IST

Hyderabad: In an anti-corruption operation, the Telangana Anti-Corruption Bureau (ACB) has arrested three individuals in Karimnagar on Tuesday night...

Punjab Bans 112 Substandard Drugs After CDSCO Warning

Himachal, UP Join States Banning Coldrif Cough Syrup After MP Deaths

Parthika Patel8 Oct 2025 6:08 PM IST

New Delhi: Among various states cracking down on toxic cough syrups, the governments of Himachal Pradesh and Uttar Pradesh have now banned Coldrif...

Ajanta Pharma Told to Revise BE Study Protocol for Cilnidipine, Metoprolol FDC

Parthika Patel7 Oct 2025 8:30 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has reviewed the proposal by Ajanta Pharma...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok